A Study Comparing SB5 to Humira® in Subjects With Moderate to Severe Rheumatoid Arthritis Despite Methotrexate Therapy

Clinical trial NCT02167139 · COMPLETED

Trial details

NCT number: NCT02167139
Sponsor: Samsung Bioepis Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Rheumatoid Arthritis

Start date: 2014-05-01
Primary completion: 2015-04-01
Enrollment: 544

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.